Showing 5761-5770 of 20939 results for "".
- Genomic Manipulations in Cancer: The Role of Viruses and Microbiomeshttps://reachmd.com/news/genomic-manipulations-in-cancer-the-role-of-viruses-and-microbiomes/2483270/The intersection of viral and bacterial genomes with human DNA is shaping a complex landscape in cancer biology: Epstein–Barr virus (EBV) and diverse microbiomes are actively propelling pathways that underlie tumor initiation and progression, setting up a tension between viral chrom
- Estrogen: A Key Player in Kidney Regeneration and Disease Protectionhttps://reachmd.com/news/estrogen-a-key-player-in-kidney-regeneration-and-disease-protection/2483272/Emerging evidence suggests estrogen engages key pathways relevant to kidney repair and may contribute to women’s lower risk of chronic kidney disease. The interactio
- NB-UVB Phototherapy Effective for Psoriasis in Skin of Colorhttps://reachmd.com/news/nb-uvb-phototherapy-effective-for-psoriasis-in-skin-of-color/2483263/A new systematic review and meta-analysis confirms that narrowband ultraviolet B (NB-UVB) phototherapy is effective for psoriasis in patients with skin of color, underscoring its role as a valuable treatment option despite the widespread adoption of biologics and systemic agents.
- Thermage® FLX Exceeds 5 Million Skin Tightening Treatmentshttps://reachmd.com/news/thermage-flx-exceeds-5-million-skin-tightening-treatments/2483284/Solta Medical, a subsidiary of Bausch Health Companies Inc., announced that more than 5 million Thermage® treatments have been performed worldwide, underscoring the global uptake of its skin tightening technology. Thermage® uses monopolar radiofrequency energy to heat skin layers and stimu
- Early Childhood Stress Tied to Psoriasis Riskhttps://reachmd.com/news/early-childhood-stress-tied-to-psoriasis-risk/2483262/A prospective cohort study from Sweden suggests that early childhood stress, particularly disruptions in family structure, may increase the risk of developing psoriasis later in life. The research, published in the Journal of Investigative Dermatology
- Balancing Medications and Movement: A Holistic Approach to Osteoporosis in the Elderlyhttps://reachmd.com/news/balancing-medications-and-movement-a-holistic-approach-to-osteoporosis-in-the-elderly/2483238/As the global population continues to age, managing osteoporosis effectively among older adults becomes a crucial health challenge. Increasing efforts are focusing on integrating pharmacological treatments with lifestyle changes to enhance bone health, underscoring a holistic approa
- Enhancing Chronic Pain Management: The Patient-Centered Approachhttps://reachmd.com/news/enhancing-chronic-pain-management-the-patient-centered-approach/2483245/Chronic pain management is moving toward patient-centered care, pairing individualized approaches with technology to improve treatment. Healthcare providers are now emphasizing personalized interventions that align with the unique needs of each patient. The integration of digital he
- Leveraging Awareness and Education for Prostate Cancer Preventionhttps://reachmd.com/news/leveraging-awareness-and-education-for-prostate-cancer-prevention/2483248/September's Prostate Cancer Awareness Month spotlights a central tension in men's health: PSA-based screening may reduce prostate cancer mortality for some, yet it can also lead to overdiagnosis and overtreatment. Awareness efforts, including webinars and community outreach, aim to
- Single vs. Multiple Doses: Optimizing Penicillin Regimens for Early Syphilishttps://reachmd.com/news/single-vs-multiple-doses-optimizing-penicillin-regimens-for-early-syphilis/2483250/The debate is continuing to simmer regarding the optimal dosing strategy for early syphilis treatment, a matter not just of clinical preferences but with significant implications for patient outcomes and healthcare logistics. With recent research reinforcing rather than overturning traditio
- NSCLC in Focus at WCLC: 3 Pivotal Trials Shaping the Next Wave of Treatmenthttps://reachmd.com/news/nsclc-in-focus-at-wclc-3-pivotal-trials-shaping-the-next-wave-of-treatment/2483234/As clinicians and researchers convene in Barcelona for the IASLC 2025 World Conference on Lung Cancer (WCLC), the stakes are high for new data poised to shift the therapeutic landscape for non-small cell lung cancer (NSCLC). Despite steady progress in immunotherapie